Quick Answer
CITIUS ONCOLOGY, INC. reported Net Income of -$24.76 million for fiscal year 2025.
CITIUS ONCOLOGY, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$24.76M | -17.1% |
| 2024 | -$21.15M | -974.2% |
| 2023 | $2.42M | +119.1% |
| 2023 | -$12.70M | -3434.3% |
| 2022 | $380.8K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$5.53M | +16.9% | -3.1% |
| June 30, 2025 | -$5.37M | -12.5% | +30.6% |
| March 31, 2025 | -$7.74M | -60.0% | -16.2% |
| December 31, 2024 | -$6.66M | -40.9% | -39.5% |
| June 30, 2024 | -$4.77M | -874.4% | +1.3% |
| March 31, 2024 | -$4.84M | -890.5% | -2.3% |
| December 31, 2023 | -$4.73M | — | -3093.1% |
| September 30, 2023 | $157.9K | — | -74.4% |
- CITIUS ONCOLOGY, INC. showed a decrease of -17.1% in Net Income compared to the prior fiscal year.
- Over the 2022–2025 period, CITIUS ONCOLOGY, INC.’s net income has declined by 6602.3% (from $380.8 thousand to -$24.76 million).
- The most recent figure is from CITIUS ONCOLOGY, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: